Summary
CVS Health (CVS) filed an 8-K on October 13, 2023, to disclose significant positive developments regarding its Medicare Star Ratings from the Centers for Medicare & Medicaid Services (CMS). The company expects an increase in its Medicare Advantage members in 4+ Star plans to 87% for the 2024 ratings, a substantial improvement from a prior projection of 21%. This upward revision is primarily attributed to a half-star improvement in the Aetna National PPO plan, which moved from 3.5 to 4.0 Stars. This improvement is crucial as it is anticipated to offset the previously disclosed revenue headwind of approximately $800 million to $1.0 billion for payment year 2024. CVS Health now expects to be eligible for bonus payments that will recover the majority of this revenue decrease in 2025. The company plans to reinvest a portion of this net improvement and will provide further details at its Investor Day on December 5, 2023. Importantly, this positive Star Rating news is not expected to impact current 2023 and 2024 financial guidance.
Key Highlights
- 1Significant improvement in Medicare Star Ratings: Expected 87% of Aetna Medicare Advantage members in 4+ Star plans for 2024 ratings (based on current enrollment), up from an unmitigated 21%.
- 2Revenue headwind mitigation: The improvement is projected to recover the majority of the previously announced $800 million to $1.0 billion headwind for payment year 2025.
- 3Key driver identified: A half-star improvement in the Aetna National PPO plan (from 3.5 to 4.0 Stars) was the primary factor for the ratings increase.
- 4Bonus payment eligibility: The company anticipates becoming eligible for bonus payments due to the improved Star Ratings, directly addressing prior revenue concerns.
- 5No impact on current guidance: The positive Star Rating news does not affect previously issued 2023 and 2024 financial guidance.
- 6Reinvestment strategy: CVS Health plans to reinvest a portion of the net financial improvement back into the business.
- 7Upcoming Investor Day: More details on the financial impact and reinvestment plans will be shared at the Investor Day on December 5, 2023.